Sanofi SNY and Roche RHHBY announced their fourth-quarter and full-year 2024 results. Novo Nordisk’s NVO novel obesity ...

Earnings Call Transcript January 30, 2025 Sanofi misses on earnings expectations. Reported EPS is $0.7 EPS, expectations were ...

Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.

The US FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients.

The FDA says that food companies will have until Jan. 15, 2027 to stop using the dye. Drugmakers will have an extra year, until January 2028, to comply with the change. Red 3, also known as ...

Jan. 14 (UPI) --The U.S. Food and Drug Administration hopes "front-of-package" labeling will better improve the American population's health, the FDA announced. "Food should be a vehicle for ...

As one of the first multinational companies to enter China in 1982, Sanofi is committed to accelerating the introduction ... of biological products guidance for industry issued by the US FDA.

Sanofi plans to submit regulatory filings for the therapy in the US and EU this year. Credit: rafaelnlins / Shutterstock. French pharmaceutical company Sanofi has reported results from its Phase III ...

The FDA headquarters at White Oak Campus. Credit: Tada Images / Shutterstock. The US Food and Drugs Administration (FDA) has confirmed that its director of the Centre for Drug Evaluation and Research ...

Also Read: Sanofi’s 340B Credit Proposal Draws Federal ... EU are planned during the first half of 2025. In September, the FDA approved Sarclisa (isatuximab) in combination with bortezomib ...

On Thursday, Sanofi SA (NASDAQ:SNY) released results from the IRAKLIA ... Regulatory submissions in the US and in the EU are planned during the first half of 2025. In September, the FDA approved ...